Income Statement Inhalation Sciences Sweden AB

Stocks

ISAB

SE0009983893

Advanced Medical Equipment & Technology

End-of-day quote SPOTLIGHT STOCK MARKET AB Other stock markets 05/08/2026			5-day change	1st Jan Change
0.1850 ^SEK	0.00%		-15.91%	-95.74%

07-29	Inhalation Sciences secures financing of up to €0.4m	FW
06-16	Inhalation Sciences Secures SEK 0.4m Research Grant	FW

8f22.Y6lU5TaLPr6LAWT4dzU9ZbpevqYngut-w_i4vBrXzCE.MP4sjH3uVfXpMyvINUZ-H-885Ohd050bt7DijiK9-HEWxhzWUcdZ18xSVA

Published financial data: INHALATION SCIENCES SWEDEN AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	9.42M	12.19M	17.5M	11.05M	3.04M
Total Revenues	9.42M	12.19M	17.5M	11.05M	3.04M
Cost of Goods Sold, Total	4.2M	2.55M	3.54M	937K	456K
Gross Profit	5.22M	9.64M	13.96M	10.11M	2.58M
Selling General & Admin Expenses, Total	11.88M	13.18M	11.08M	8.96M	8.61M
R&D Expenses	9.93M	8.84M	7.12M	6.74M	4.15M
Depreciation & Amortization - (IS)	-	-	-	-	-
Other Operating Expenses	-16K	-351K	-480K	-516K	-21K
Other Operating Expenses, Total	21.79M	21.67M	17.72M	15.19M	12.74M
Operating Income	-16.57M	-12.02M	-3.76M	-5.08M	-10.16M
Interest Expense, Total	-38K	-103K	-995K	-77K	-13K
Interest And Investment Income	-	4K	7K	6K	8K
Net Interest Expenses	-38K	-99K	-988K	-71K	-5K
Other Non Operating Income (Expenses)	-	-1K	-	-	-
EBT, Excl. Unusual Items	-16.61M	-12.12M	-4.74M	-5.15M	-10.16M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
EBT, Incl. Unusual Items	-16.61M	-12.12M	-4.74M	-5.15M	-10.16M
Earnings From Continuing Operations	-16.61M	-12.12M	-4.74M	-5.15M	-10.16M
Net Income to Company	-16.61M	-12.12M	-4.74M	-5.15M	-10.16M
Minority Interest	-	-	-	-	-
Net Income - (IS)	-16.61M	-12.12M	-4.74M	-5.15M	-10.16M
Net Income to Common Incl Extra Items	-16.61M	-12.12M	-4.74M	-5.15M	-10.16M
Net Income to Common Excl. Extra Items	-16.61M	-12.12M	-4.74M	-5.15M	-10.16M
Per Share Items
Net EPS - Basic	-1.64	-1.07	-0.36	-0.34	-0.35
Basic EPS - Continuing Operations	-1.64	-1.07	-0.36	-0.34	-0.35
Basic Weighted Average Shares Outstanding	10.16M	11.38M	13.27M	15.17M	29.08M
Net EPS - Diluted	-1.64	-1.07	-0.36	-0.34	-0.35
Diluted EPS - Continuing Operations	-1.64	-1.07	-0.36	-0.34	-0.35
Diluted Weighted Average Shares Outstanding	10.16M	11.38M	13.27M	15.17M	29.08M
Normalized Basic EPS	-1.02	-0.67	-0.22	-0.21	-0.22
Normalized Diluted EPS	-1.02	-0.67	-0.22	-0.21	-0.22
Supplemental Items
EBITDA	-16.32M	-11.78M	-3.57M	-4.94M	-10.04M
EBITA	-16.57M	-12.02M	-3.76M	-5.08M	-10.16M
EBIT	-16.57M	-12.02M	-3.76M	-5.08M	-10.16M
EBITDAR	-15.56M	-10.98M	-2.72M	-4.08M	-9.19M
Total Revenues (As Reported)	-	-	-	-	-
Normalized Net Income	-10.38M	-7.58M	-2.96M	-3.22M	-6.35M
Supplemental Operating Expense Items
Selling and Marketing Expenses	6.47M	7.96M	6.16M	4.92M	4.23M
Research And Development Expense From Footnotes	9.93M	8.84M	7.12M	6.74M	4.15M
Net Rental Expense, Total	770K	801K	844K	853K	851K
Imputed Operating Lease Interest Expense	114K	414K	5.53M	686K	-
Imputed Operating Lease Depreciation	656K	387K	-4.69M	167K	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	14.4M	1.84M	7.82M	4.44M	2.83M
Total Cash And Short Term Investments	14.4M	1.84M	7.82M	4.44M	2.83M
Accounts Receivable, Total	2.6M	2.66M	3.81M	1.4M	999K
Other Receivables	516K	236K	497K	252K	530K
Total Receivables	3.11M	2.89M	4.3M	1.65M	1.53M
Inventory	3.52M	4.24M	3.24M	2.92M	3.09M
Prepaid Expenses	454K	525K	423K	263K	1.28M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	21.48M	9.5M	15.8M	9.28M	8.74M
Gross Property Plant And Equipment	2.9M	2.61M	2.61M	2.61M	2.61M
Accumulated Depreciation	-1.86M	-1.77M	-1.96M	-2.1M	-2.21M
Net Property Plant And Equipment	1.04M	837K	651K	512K	399K
Long-term Investments	-	-	-	-	-
Deferred Charges Long-Term	3.58M	2.65M	1.72M	735K	390K
Other Long-Term Assets, Total	1K	-	-	-	-
Total Assets	26.11M	12.98M	18.17M	10.53M	9.53M
Liabilities
Accounts Payable, Total	2.26M	1.74M	1.08M	920K	469K
Accrued Expenses, Total	1.5M	1.08M	1.22M	666K	421K
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	482K	480K	648K	442K	-
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	180K	474K	1M	115K	601K
Other Current Liabilities	647K	796K	819K	579K	775K
Total Current Liabilities	5.07M	4.57M	4.77M	2.72M	2.27M
Long-Term Debt	1.37M	858K	442K	-	-
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	6.43M	5.43M	5.21M	2.72M	2.27M
Common Stock, Total	4.55M	4.55M	6.07M	6.07M	1.29M
Additional Paid In Capital	82.55M	82.73M	94.71M	94.71M	104M
Retained Earnings	-70.96M	-83.08M	-89.55M	-93.71M	-98.75M
Comprehensive Income and Other	3.54M	3.36M	1.72M	735K	389K
Total Common Equity	19.68M	7.55M	12.95M	7.81M	7.26M
Minority Interest	-	-	-	-	-
Total Equity	19.68M	7.55M	12.95M	7.81M	7.26M
Total Liabilities And Equity	26.11M	12.98M	18.17M	10.53M	9.53M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	11.38M	11.38M	15.17M	15.17M	39.17M
ECS Total Common Shares Outstanding	11.38M	11.38M	15.17M	15.17M	39.17M
Book Value / Share	1.73	0.66	0.85	0.51	0.19
Tangible Book Value	19.68M	7.55M	12.95M	7.81M	7.26M
Tangible Book Value Per Share	1.73	0.66	0.85	0.51	0.19
Total Debt	1.85M	1.34M	1.09M	442K	0
Net Debt	-12.55M	-501K	-6.74M	-4M	-2.83M
Debt Equivalent Oper. Leases	6.16M	6.41M	6.75M	6.82M	6.81M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	2.9M	2.61M	2.61M	2.61M	2.61M
Full Time Employees	9	9	8	6	5

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-16.61M	-12.12M	-4.74M	-5.15M	-10.16M
Depreciation & Amortization - CF	246K	246K	187K	139K	113K
Depreciation & Amortization, Total	246K	246K	187K	139K	113K
Amortization of Deferred Charges, Total - (CF)	933K	933K	930K	987K	345K
Other Operating Activities, Total	307K	0	0	0	0
Change In Accounts Receivable	-824K	150K	-1.31M	2.82M	-972K
Change In Inventories	-1.38M	-719K	998K	318K	-170K
Change in Other Net Operating Assets	-1.42M	-492K	197K	-2.05M	58K
Cash from Operations	-18.74M	-12.01M	-3.74M	-2.94M	-10.79M
Capital Expenditure	-152K	-40K	-	-	-
Sale (Purchase) of Intangible assets	-45K	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Cash from Investing	-197K	-40K	-	-	-
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	1.8M	-	-
Total Debt Issued	-	-	1.8M	-	-
Long-Term Debt Repaid, Total	-525K	-509K	-2.22M	-443K	-442K
Total Debt Repaid	-525K	-509K	-2.22M	-443K	-442K
Issuance of Common Stock	27.4M	-	13.65M	-	12M
Other Financing Activities, Total	-1.59M	-	-3.5M	-	-2.39M
Cash from Financing	25.29M	-509K	9.73M	-443K	9.17M
Net Change in Cash	6.35M	-12.56M	5.99M	-3.38M	-1.61M
Supplemental Items
Cash Interest Paid	-	-	995K	77K	13K
Levered Free Cash Flow	-12.84M	-7.5M	-2.14M	-806K	-6.98M
Unlevered Free Cash Flow	-12.81M	-7.44M	-1.51M	-758K	-6.97M
Change In Net Working Capital	3.44M	1.06M	283K	-1.29M	1.08M
Net Debt Issued / Repaid	-525K	-509K	-416K	-443K	-442K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-46.44	-38.45	-15.07	-22.11	-63.29
Return on Total Capital	-60.48	-49.42	-20.47	-28.46	-81.84
Return On Equity %	-110.16	-89.05	-46.27	-49.58	-134.86
Return on Common Equity	-110.16	-89.05	-46.27	-49.58	-134.86
Margin Analysis
Gross Profit Margin %	55.4	79.08	79.77	91.52	85
SG&A Margin	126.05	108.08	63.32	81.09	283.13
EBITDA Margin %	-173.26	-96.6	-20.39	-44.69	-330.22
EBITA Margin %	-175.88	-98.61	-21.46	-45.95	-333.94
EBIT Margin %	-175.88	-98.61	-21.46	-45.95	-333.94
Income From Continuing Operations Margin %	-176.28	-99.43	-27.1	-46.59	-334.1
Net Income Margin %	-176.28	-99.43	-27.1	-46.59	-334.1
Net Avail. For Common Margin %	-176.28	-99.43	-27.1	-46.59	-334.1
Normalized Net Income Margin	-110.17	-62.15	-16.94	-29.12	-208.81
Levered Free Cash Flow Margin	-136.24	-61.51	-12.2	-7.29	-229.56
Unlevered Free Cash Flow Margin	-135.99	-60.99	-8.65	-6.86	-229.3
Asset Turnover
Asset Turnover	0.42	0.62	1.12	0.77	0.3
Fixed Assets Turnover	8.64	12.97	23.53	19	6.68
Receivables Turnover (Average Receivables)	4.46	4.64	5.42	4.24	2.54
Inventory Turnover (Average Inventory)	1.48	0.66	0.95	0.3	0.15
Short Term Liquidity
Current Ratio	4.24	2.08	3.31	3.41	3.86
Quick Ratio	3.46	1.03	2.54	2.24	1.92
Operating Cash Flow to Current Liabilities	-3.7	-2.63	-0.78	-1.08	-4.76
Days Sales Outstanding (Average Receivables)	81.91	78.62	67.39	86.24	143.85
Days Outstanding Inventory (Average Inventory)	246	555.23	385.62	1.2K	2.41K
Average Days Payable Outstanding	129.65	223.24	202.74	591.28	404.94
Cash Conversion Cycle (Average Days)	198.26	410.6	250.27	699.21	2.15K
Long Term Solvency
Total Debt/Equity	9.4	17.71	8.41	5.66	-
Total Debt / Total Capital	8.59	15.05	7.76	5.36	-
LT Debt/Equity	6.95	11.36	3.41	-	-
Long-Term Debt / Total Capital	6.35	9.65	3.15	-	-
Total Liabilities / Total Assets	24.64	41.83	28.7	25.85	23.78
EBIT / Interest Expense	-436.08	-116.75	-3.77	-65.92	-781.15
EBITDA / Interest Expense	-429.61	-114.36	-3.59	-64.12	-772.46
(EBITDA - Capex) / Interest Expense	-433.61	-114.75	-3.59	-64.12	-772.46
Total Debt / EBITDA	-0.11	-0.11	-0.31	-0.09	-
Net Debt / EBITDA	0.77	0.04	1.89	0.81	0.28
Total Debt / (EBITDA - Capex)	-0.11	-0.11	-0.31	-0.09	-
Net Debt / (EBITDA - Capex)	0.76	0.04	1.89	0.81	0.28
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-7.05	29.42	43.55	-36.89	-72.47
Gross Profit, 1 Yr. Growth %	-22.78	84.73	44.8	-27.59	-74.43
EBITDA, 1 Yr. Growth %	92.08	-27.85	-69.7	38.33	103.4
EBITA, 1 Yr. Growth %	89.58	-27.43	-68.77	35.14	100.06
EBIT, 1 Yr. Growth %	89.58	-27.43	-68.77	35.14	100.06
Earnings From Cont. Operations, 1 Yr. Growth %	-268.19	-27	-60.87	8.49	97.4
Net Income, 1 Yr. Growth %	-268.19	-27	-60.87	8.49	97.4
Normalized Net Income, 1 Yr. Growth %	73.03	-27	-60.87	8.49	97.4
Diluted EPS Before Extra, 1 Yr. Growth %	-243.46	-34.58	-66.36	-5.56	2.94
Accounts Receivable, 1 Yr. Growth %	59.13	2.27	43.37	-63.29	-28.54
Inventory, 1 Yr. Growth %	64.3	20.42	-23.54	-9.81	5.81
Net Property, Plant and Equip., 1 Yr. Growth %	-8.35	-19.75	-22.22	-21.35	-22.07
Total Assets, 1 Yr. Growth %	41.24	-50.27	39.92	-42.05	-9.52
Tangible Book Value, 1 Yr. Growth %	87.86	-61.62	71.51	-39.73	-6.99
Common Equity, 1 Yr. Growth %	87.86	-61.62	71.51	-39.73	-6.99
Cash From Operations, 1 Yr. Growth %	264.54	-35.93	-68.83	-21.53	267.25
Capital Expenditures, 1 Yr. Growth %	204	-73.68	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	396.89	-41.57	-71.53	-62.27	766.53
Unlevered Free Cash Flow, 1 Yr. Growth %	525.9	-41.96	-79.65	-49.95	820.51
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.61	9.68	36.3	-4.82	-58.32
Gross Profit, 2 Yr. CAGR %	-5.26	19.44	63.55	2.39	-56.97
EBITDA, 2 Yr. CAGR %	45.56	17.73	-53.24	-35.26	67.74
EBITA, 2 Yr. CAGR %	44.87	17.29	-52.39	-35.03	64.43
EBIT, 2 Yr. CAGR %	44.87	17.29	-52.39	-35.03	64.43
Earnings From Cont. Operations, 2 Yr. CAGR %	95.51	10.81	-46.56	-34.85	46.34
Net Income, 2 Yr. CAGR %	95.51	10.81	-46.56	-34.85	46.34
Normalized Net Income, 2 Yr. CAGR %	34.6	12.39	-46.56	-34.85	46.34
Diluted EPS Before Extra, 2 Yr. CAGR %	80.12	-3.12	-53.08	-43.63	-1.4
Accounts Receivable, 2 Yr. CAGR %	20.86	27.57	21.09	-27.45	-48.78
Inventory, 2 Yr. CAGR %	10.76	40.66	-4.04	-16.96	-2.31
Net Property, Plant and Equip., 2 Yr. CAGR %	-11.44	-14.24	-21	-21.79	-21.71
Total Assets, 2 Yr. CAGR %	5.26	-16.19	-16.59	-9.95	-27.59
Tangible Book Value, 2 Yr. CAGR %	93.79	-15.09	-18.86	1.67	-25.13
Common Equity, 2 Yr. CAGR %	93.79	-15.09	-18.86	1.67	-25.13
Cash From Operations, 2 Yr. CAGR %	46.07	52.82	-55.31	-50.54	69.75
Capital Expenditures, 2 Yr. CAGR %	-49.96	-10.56	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	25.51	70.4	-59.21	-67.23	80.81
Unlevered Free Cash Flow, 2 Yr. CAGR %	32.56	90.6	-65.63	-68.08	114.64
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	20.08	10.86	19.97	5.45	-37.06
Gross Profit, 3 Yr. CAGR %	11.74	18.36	27.35	24.65	-35.52
EBITDA, 3 Yr. CAGR %	12.09	15.2	-25.12	-32.88	-5.18
EBITA, 3 Yr. CAGR %	12.04	15.05	-24.54	-32.59	-5.48
EBIT, 3 Yr. CAGR %	12.04	15.05	-24.54	-32.59	-5.48
Earnings From Cont. Operations, 3 Yr. CAGR %	11.81	40.79	-21.68	-32.33	-5.72
Net Income, 3 Yr. CAGR %	11.81	40.79	-21.68	-32.33	-5.72
Normalized Net Income, 3 Yr. CAGR %	11.81	9.77	-20.94	-32.33	-5.72
Diluted EPS Before Extra, 3 Yr. CAGR %	5.83	28.51	-31.9	-40.76	-31.1
Accounts Receivable, 3 Yr. CAGR %	-3.71	14.31	32.64	-18.65	-27.82
Inventory, 3 Yr. CAGR %	41.42	13.89	14.8	-6.01	-9.97
Net Property, Plant and Equip., 3 Yr. CAGR %	4.5	-14.3	-16.99	-21.11	-21.88
Total Assets, 3 Yr. CAGR %	9.94	-18.02	-0.58	-26.12	-9.81
Tangible Book Value, 3 Yr. CAGR %	22.12	12.96	7.34	-26.52	-1.31
Common Equity, 3 Yr. CAGR %	22.12	12.96	7.34	-26.52	-1.31
Cash From Operations, 3 Yr. CAGR %	21.5	10.98	-10.04	-46.09	-3.51
Capital Expenditures, 3 Yr. CAGR %	-	-59.61	-	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	25.61	-2.72	-6.15	-60.26	-2.37
Unlevered Free Cash Flow, 3 Yr. CAGR %	26.28	0.66	-9.58	-61.04	-2.12
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.16	8.74	26.33	4.3	-21.4
Gross Profit, 5 Yr. CAGR %	-9.04	5.1	30.14	11.69	-17.49
EBITDA, 5 Yr. CAGR %	30.7	14.18	-20.99	-8.52	3.39
EBITA, 5 Yr. CAGR %	26.47	14.06	-20.44	-8.46	3.04
EBIT, 5 Yr. CAGR %	26.47	14.06	-20.44	-8.46	3.04
Earnings From Cont. Operations, 5 Yr. CAGR %	25.36	13.78	-16.78	3.45	0.57
Net Income, 5 Yr. CAGR %	25.36	13.78	-16.78	3.45	0.57
Normalized Net Income, 5 Yr. CAGR %	25.36	13.78	-16.78	-10.9	1.14
Diluted EPS Before Extra, 5 Yr. CAGR %	-11.91	-0.37	-23.57	-7.58	-21.04
Accounts Receivable, 5 Yr. CAGR %	176.74	-5.17	5.53	-4.7	-9.35
Inventory, 5 Yr. CAGR %	40.64	67.04	21.1	0.37	7.62
Net Property, Plant and Equip., 5 Yr. CAGR %	-3.29	-9.05	-6.56	-17.38	-18.91
Total Assets, 5 Yr. CAGR %	20.15	-11.05	-1.56	-14.88	-12.42
Tangible Book Value, 5 Yr. CAGR %	36.67	-13.85	3.69	8.3	-7.07
Common Equity, 5 Yr. CAGR %	36.67	-13.85	3.69	8.3	-7.07
Cash From Operations, 5 Yr. CAGR %	27.12	12.07	-18.56	-19.67	15.97
Capital Expenditures, 5 Yr. CAGR %	-43.7	17.32	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	19.95	2.74	-19.9	-37.05	22
Unlevered Free Cash Flow, 5 Yr. CAGR %	20.63	2.92	-24.96	-36.42	27.78